“Tapinarof 1% Cream: A Novel Treatment for Adult Plaque Psoriasis with Anti-inflammatory Effects and Good Safety Profile.”

https://pubmed.ncbi.nlm.nih.gov/38117596

Tapinarof 1% cream is a novel, nonsteroidal treatment for adult plaque psoriasis that downregulates IL-17, reduces inflammation, improves skin barrier proteins, and has a favorable safety profile.